Global Health Catalyst (GHC) Summit

项目摘要 最近，来自美国和14个经济不同国家的癌症政策领导人得出结论 控制癌症的成功运动将越来越依赖于国际社会的协调一致 合作。世界卫生组织最近的癌症报告强调了这样做的紧迫性 国际合作，1400万新癌症病例中超过60%，820万新癌症病例中70% 每年发生在低收入和中等收入国家(LMIC)的死亡人数，可悲的是，其中一些 在没有某种形式的合作的情况下，最没有能力应对癌症的人。这些专业 癌症死亡人数的差异在一定程度上反映了辐射方面的根本性差异。 肿瘤学。例如，放射治疗是治疗50%以上癌症所需的 初步研究显示，在非洲54个国家中，约有一半的国家没有提供这种药物 在可能的情况下实施放射治疗的主要安全问题。这个项目的总体目标是 提案是组织年度全球健康催化剂(GHC)癌症峰会，旨在催化 美国和非洲机构之间的高影响力国际合作，以解决 不断增长的全球癌症负担，以及相关的差异。本次GHC峰会将在 过去几年在以往组织的首脑会议上取得的成功和吸取的教训， 促进了合作，以支持不同非洲的癌症医疗机构 支持教育和培训工作，以建设人力/研究能力； 建立了卓有成效的研究合作，以及疾病预防和宣传 全球肿瘤学课程。首脑会议的一个创新部分是注重外联。 代表不足的少数群体和资源丰富的非洲人参与散居海外(援助) 将人才外流的破坏性影响转化为抗击癌症。结果将包括：新的 并加强了由美国和非洲机构的合作伙伴参与的合作 年，未得到充分代表的少数群体和散居国外的人显著增加了参与全球 肿瘤学，由美国和非洲合作者共同撰写的同行评议出版物，联合 来自研究合作的专利，以及不断增长的参与度 美国和非洲机构参与应对日益严重的全球癌症负担 以及相关的差异。

Project Summary Recently, leaders in cancer policy from the USA and 14 economically diverse countries concluded that successful campaigns to control cancer will increasingly depend on concerted international collaborations. The recent World Health Organization Cancer Report highlights urgency for such international collaborations, with over 60% of 14 million new cancer cases and 70% of 8.2 million deaths per year occurring in low and middle income countries (LMIC), some of which, sadly, are the least capable of dealing with cancer without some form of collaboration. These major disparities in cancer deaths are in part a reflection of poignant underlying disparities in Radiation Oncology. For example, radiotherapy, which is needed in the treatment of over 50% of cancer patients, is not available in about half of Africa's 54 countries, and preliminary research shows major safety concerns in implementation of radiotherapy where available. The overall goal of this proposal is to organize yearly global health catalyst (GHC) cancer summits designed to catalyze high impact international collaborations between US and African Institutions to address the growing global burden of cancers, and associated disparities. This GHC summits, will build on the success and lessons learned over the past years during previously organized summits, that have catalyzed collaborations to support cancer healthcare institutions in different African countries, supported education and training efforts to build human/research capacity, and established fecund research collaborations, along with disease prevention and advocacy programs in global oncology. An innovative component of the summit is the focus on outreach engagement of under-represented minorities and the resource-laden Africans in Diaspora (AiD) to turn the devastating effects of brain drain to gain against cancer. Outcomes will include: new and strengthened collaborations involving partners from both USA and African institutions each year, significant increase in participation of under-represented minorities and diaspora in global oncology, peer-reviewed publications co-authored by both USA and African collaborators, joint patents resulting from research collaborations, and continuous growth to engage more participation from USA and African Institutions to address the growing global burden of cancer and associated disparities.